Taylor Jordan, Stiepel Henry R, Keefe Nicole
Department of Radiology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Semin Intervent Radiol. 2022 Nov 17;39(4):364-372. doi: 10.1055/s-0042-1757314. eCollection 2022 Aug.
Effective revascularization of peripheral artery disease relies on periprocedural pharmacological regulation of the clotting cascade. Patient-specific factors such as cardiovascular risk factors, contraindications, and individual psychosocial factors must be considered when initiating post revascularization management. Management with anticoagulant and antiplatelet agents is discussed to guide the interventionalist on which therapy may be appropriate for their patient. While exact treatment may be institution and provider dependent, the interventionist must be familiar with the available classes of medications and how they can be prescribed in the postprocedural setting to improve cardiovascular outcomes.
外周动脉疾病的有效血运重建依赖于围手术期对凝血级联反应的药物调节。在启动血运重建后管理时，必须考虑患者特定因素，如心血管危险因素、禁忌症和个体心理社会因素。讨论了使用抗凝剂和抗血小板药物的管理方法，以指导介入医生选择适合其患者的治疗方法。虽然确切的治疗方法可能因机构和提供者而异，但介入医生必须熟悉可用的药物类别以及如何在术后环境中开具这些药物以改善心血管结局。
